StockGlow

Novartis AG (NVS.BA)

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

61,600.00-0.01%Healthcare
Compare NVS.BA with
StockGlow Score
87
Bullish
BearishBullish
1 year ago+55.9%

The outlook

Novartis AG currently reads as bullish based on above its 50- & 200-day averages, 81% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range81% of the way from its 52-week low to high
Market cap
$58.54T
52-wk high
67,200.00
52-wk low
37,525.00
50-day avg
58,961.50
200-day avg
55,364.25
Trailing P/E
3.1

Similar stocks

MRK.BAMERCK & CO INC CEDEAR (5 REP 1 $41,060.00+1.28%AMGN.BAAmgen Inc.$20,260.00+0.65%AZN.BAAstraZeneca PLC$66,975.00-0.07%TXN.BATexas Instruments Incorporated$87,475.00+0.57%SAP.BASAP SE$48,280.00+2.12%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy